Page last updated: 2024-08-25

alantolactone and Cancer of Mouth

alantolactone has been researched along with Cancer of Mouth in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, Z; Chen, S; Deng, Z; Ding, X; Huang, K; Li, J; Mao, Y; Ping, Y; Sun, X; Tu, C; Wu, G; Wu, T; Yang, B; Yang, Z; Zhang, Y; Zhao, Z; Zou, P1

Other Studies

1 other study(ies) available for alantolactone and Cancer of Mouth

ArticleYear
Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
    Journal of translational medicine, 2023, 05-18, Volume: 21, Issue:1

    Topics: Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Down-Regulation; Dynamins; Humans; Mitochondria; Mouth Neoplasms; Phosphorylation; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck

2023